Patent · US Active

Sulfonamide compounds or salts thereof

US8314240B2 · kind B2 · utility

3Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2009
Grant dateNov 20, 2012
Priority date
Expiry dateJun 24, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

[Object] A compound which is useful as an EP1 receptor antagonist is provided.[Means for Solution] The present inventors investigated EP1 receptor antagonists, and confirmed that a compound having a sulfonamide structure, in which the nitrogen atom of the sulfonamide structure is substituted with 2-fluoropropyl group, 3-fluoro-2-methylpropyl group or the like, has a potent EP1 receptor antagonistic action, thereby completing the present invention. The sulfonamide compound of the present invention has a potent EP1 receptor antagonistic action and can be used as an agent for preventing and/or treating a lower urinary tract symptom or the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.